LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study

被引：0
|
作者：
Corradi, Massimo
Spinola, Monica
Guasconi, Alessandro
Cohuet, Geraldine
Montagna, Isabella
Bizzi, Andrea
Petruzzelli, Stefano
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Anti-inflammatory; Chronic disease;
D O I：
10.1183/13993003.congress-2016.OA4831
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA4831
引用
收藏
页数：2
相关论文
共 18 条
  • [1] Extrafine Formulation of Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium (BDP/FF/G) and Exacerbation Recurrence: Post-Hoc Analysis of the TRINITY Study
    Scuri, M.
    Fabbri, L. M.
    Singh, D.
    Vestbo, J.
    Corradi, M.
    Guasconi, A.
    Montagna, I.
    Cohuet, G.
    Vezzoli, S.
    Petruzzelli, S.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Extrafine beclometasone dipropionate, formoterol fumarate, glycopyrronium (BDP/FF/G) and exacerbation recurrence: post-hoc analysis of the TRIBUTE study.
    Fabbri, Leonardo
    Singh, Dave
    Vestbo, Jorgen
    Corradi, Massimo
    Guasconi, Alessandro
    Scuri, Mario
    Georges, George
    Montagna, Isabella
    Prunier, Helene
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] LATE-BREAKING ABSTRACT: TRILOGY: a phase III study to evaluate the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) in COPD patients
    Singh, Dave
    Papi, Alberto
    Corradi, Massimo
    Montagna, Isabella
    Francisco, Catherine
    Cohuet, Geraldine
    Vezzoli, Stefano
    Muraro, Annamaria
    Petruzzelli, Stefano
    Scuri, Mario
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [4] CHF5993 pMDI (extrafine Beclometasone Dipropionate: BDP, Formoterol Fumarate: FF, Glycopyrronium Bromide: GB) reduces Clinically Important Deteriorations (CID) in COPD: post-hoc analysis of TRILOGY study
    Singh, Dave
    Papi, Alberto
    Vezzoli, Stefano
    Spinola, Monica
    Scuri, Mario
    Muraro, Annamaria
    Petruzzelli, Stefano
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [5] Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY
    Singh, Dave
    Fabbri, Leonardo
    Papi, Alberto
    Vezzoli, Stefano
    Muraro, Annamaria
    Petruzzelli, Stefano
    Curi, Mario S.
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] LATE-BREAKING ABSTRACT: TRINITY: A phase III study to compare the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) with tiotropium (Tio) and a free triple combination of BDP/FF (Foster®) plus Tio in COPD patients
    Vestbo, Jorgen
    Corradi, Massimo
    Montagna, Isabella
    Cohuet, Geraldine
    Francisco, Catherine
    Vezzoli, Stefano
    Muraro, Annamaria
    Petruzzelli, Stefano
    Scuri, Mario
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] Late Breaking Abstract - Reduction of COPD exacerbations with extrafine single inhaler triple therapy: post-hoc analysis by exacerbation treatment of the TRIBUTE study
    Fabbri, Leonardo
    Singh, Dave
    Valente, Ilaria
    Guasconi, Alessandro
    Prunier, Helene
    Georges, George
    Papi, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [8] ASSOCIATION OF INCIDENT PNEUMONIA AND EXACERBATIONS WITH EXTRAFINE TRIPLE THERAPY IN ONE SINGLE INHALER IN COPD PATIENTS: A POST-HOC ANALYSIS FROM TRILOGY AND TRINITY STUDIES
    Scuri, M.
    Vestbo, J.
    Papi, A.
    Corradi, M.
    Spinola, M.
    Montagna, I.
    Francisco, C.
    Cohuet, G.
    Vezzoli, S.
    Muraro, A.
    Petruzzelli, S.
    Singh, D.
    THORAX, 2017, 72 : A231 - +
  • [9] Association Of Incident Pneumonia And Exacerbations With Extrafine Triple Therapy In One Single Inhaler In COPD Patients: A Post-Hoc Analysis From Trilogy And Trinity Studies
    Scuri, M.
    Vestbo, J.
    Papi, A.
    Corradi, M.
    Spinola, M.
    Montagna, I.
    Francisco, C.
    Cohuet, G.
    Vezzoli, S.
    Muraro, A.
    Petruzzelli, S.
    Singh, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] The efficacy of extrafine beclomethasone dipropionate-formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study
    Singh, Dave
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3263 - 3271
12